Atrophic Scar Clinical Trial
Official title:
A Phase 1, Single-Center, Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of Single Dose of TRTP-101 in Adults With Atrophic Scars
The purpose of this clinical trial was to evaluate the safety and tolerability for 12 weeks after one dose of TRTP-101 in adults with atrophic scars.
A phase 1 clinical trial to evaluate dose-limiting toxicity by administering a singe dose of TRTP-101 to each of the four sites of atrophic scar. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06000839 -
A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology)
|
N/A | |
| Recruiting |
NCT05936437 -
Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment
|
N/A | |
| Active, not recruiting |
NCT04519515 -
Vollure for the Correction of Atrophic Facial Scarring
|
N/A | |
| Not yet recruiting |
NCT06298591 -
The Efficacy of Combination Therapy in Atrophic Scars
|
N/A | |
| Completed |
NCT03264573 -
Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars
|
N/A | |
| Not yet recruiting |
NCT05695807 -
Carboxytherapy in the Treatment of Atrophic Scars
|
N/A | |
| Completed |
NCT05686603 -
Comparison of Picosecond Lasers vs. Ablative Fractional Er:YAG Lasers in Treating Atrophic Scar
|
N/A |